Radiology Doctors in Sheridan, WY Accepting Medicare

4 Radiology doctors found. Showing 1 - 4

Dr. John P Stamato, M.D. Radiology - Radiation Oncology Medicare: Accepting Medicare Assignments Practice Location: 1585 W 5th St, Welch Cancer Center, Sheridan, WY 82801 Phone: 307-674-6022    Fax: 307-672-9566

Dr. Daniel Robert Alzheimer, M.D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1401 W 5th St, Sheridan, WY 82801 Phone: 307-672-1048    Fax: 307-674-6887

William Byron Taylor Iii, M.D. Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1401 W 5th St, Sheridan, WY 82801 Phone: 307-674-6884    Fax: 307-674-6887

Shaun Jeffrey Gonda, MD Radiology - Diagnostic Radiology Medicare: Accepting Medicare Assignments Practice Location: 1401 W 5th St, Sheridan, WY 82801 Phone: 307-672-1000

News Archive

Brain hypoxia associated with poor short-term outcome after severe TBI

Low oxygen supply (hypoxia) to vulnerable brain tissue is a major contributor to the risk of death or major disability after severe traumatic brain injury (TBI), reports a study in the November issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Single engineered protein blocks two related angiogenic receptors

Cancer needs blood. In fact, some cancer medications work solely to slow or prevent cancer cells from creating new capillaries, choking off their much-needed blood and nutrient supply to halt the growth of tumors.

Obesity linked to mortality gap between Black and white women with early breast cancer

In an analysis of women with early breast cancer, Black women had higher rates of obesity and other health conditions that can affect survival, compared with white women.

CIGNA launches new office and operations in Turkey

CIGNA, a leader in direct marketed supplemental health, life and accident insurance in the international marketplace, today announced the launch of a new office and operations in Turkey.

Micell initiates enrollment in DESSOLVE II MiStent Drug-Eluting Coronary Stent System trial

Micell Technologies,™ Inc. today announced it has enrolled the first patient in the DESSOLVE II (DES with Sirolimus and a bioabsorbable pOLymer for the treatment of patients with de noVo lEsions in the native coronary arteries) clinical trial. Stefan Verheye, M.D., Ph.D. at Middelheim Hospital, Antwerp, Belgium enrolled the first patient in the study. This clinical investigation is being conducted to support CE Mark approval of the company's MiStent™ Drug-Eluting Coronary Stent System (MiStent DES).

Read more Medical News

› Verified 2 days ago